AZ researches kidney and lung drugs with BenevolentAI

AZ researches kidney and lung drugs with BenevolentAI

Source: 
Pharmaforum
snippet: 

AstraZeneca has become the latest big pharma to jump on the artificial intelligence R&D bandwagon, penning a deal with the UK’s BenevolentAI to find new kidney and lung drugs.